Adjusting insulin delivery rates

US2025262381A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025262381-A1
Application numberUS-202519197435-A
CountryUS
Kind codeA1
Filing dateMay 2, 2025
Priority dateJan 14, 2016
Publication dateAug 21, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method may include delivering insulin, using an insulin pump and a controller, over a first diurnal time period based on a baseline basal insulin rate stored in memory. The controller may receive blood glucose data to control delivery of insulin via the insulin pump in amounts variable from the baseline basal insulin rate to control blood glucose levels for a person with diabetes (PWD). The method may also include modifying the baseline basal insulin rate stored in the memory for a second diurnal time period that is at least 20 hours after the first diurnal period based on an amount of insulin actually delivered during the first diurnal time period.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method comprising: during a first period of time, monitoring a rate at which insulin is delivered; determining a difference between a first baseline basal rate previously associated with the first period of time and the rate at which insulin was delivered; based at least partially on the determined difference, determining a second baseline basal rate to be utilized to deliver insulin during a second period of time that is at least 20 hours after an occurrence of the first period of time; and delivering insulin during the second period of time according to the second baseline basal rate. 2 . The method of claim 1 , wherein determining the second baseline basal rate comprising calculating the second baseline basal rate such that a difference between the second baseline basal rate and a third baseline basal rate originally associated with the second period of time is less than a difference between the first baseline basal insulin rate and the rate at which insulin was delivered during the first period of time. 3 . The method of claim 1 , further comprising calculating an updated carbohydrate-to-insulin ratio (CR) for the second period of time based at least partially on the rate at which insulin was delivered during the first period of time. 4 . The method of claim 1 , further comprising calculating an updated insulin sensitivity factor (ISF) for the second period of time based at least partially on the rate at which insulin was delivered during the first period of time. 5 . The method of claim 1 , wherein a commencement of the second period of time is 24 hours after a commencement of the first period of time. 6 . The method of claim 1 , wherein a commencement of the second period of time is at least 22 hours after a commencement of the first period of time. 7 . The method of claim 1 , wherein the second baseline basal rate is an increased rate relative to a third baseline basal rate originally associated with the second period of time if a ratio of the rate at which insulin was delivered during the first period of time to the first baseline basal insulin rate for the first period of time exceeds a predetermined first threshold and is a decreased rate relative to the third baseline basal rate if the ratio falls below a predetermined second threshold. 8 . The method of claim 7 , wherein the second baseline basal rate is the increased rate or the decreased rate relative to the third baseline basal rate by a fixed amount or a percentage that is less than a difference between the rate at which insulin was delivered during the first period of time and the first baseline basal insulin rate. 9 . The method of claim 8 , wherein the second baseline basal rate is an increased rate or a decreased rate relative to the third baseline basal rate by a percentage between about 1% and about 5% of the third baseline basal rate. 10 . The method of claim 8 , further comprising calculating an updated CR or an updated ISF for the second period of time, wherein the updated CR or an updated ISF is increased or decreased by a fixed amount or percentage. 11 . The method of claim 10 , wherein the updated CR or the updated ISF is increased or decreased relative to an original CR or an original ISF by a percentage between about 1% and about 5%, and wherein the second baseline basal rate is an increased rate or a decreased rate relative to the third baseline basal rate by a percentage between about 1% and about 5%. 12 . The method of claim 7 , wherein a difference between the second baseline basal rate and the third baseline basal rate is based at least partially on the ratio, but is less than a difference between the rate at which insulin was delivered during the first period of time and the first baseline basal insulin rate. 13 . The method of claim 7 , further comprising calculating an updated CR or an updated ISF for the second period of time, wherein the updated CR or an updated ISF is increased when the second baseline basal rate is less than the third baseline basal rate and decreased when the second baseline basal rate is greater than the third baseline basal rate. 14 . A system comprising: an insulin pump configured to deliver insulin; a glucose sensor configured to generate glucose data; and a controller comprising: at least one processor; and at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the controller to: during a first period of time, monitor a rate at which insulin is delivered; determine a difference between a first baseline basal rate previously associated with the first period of time and the rate at which insulin was delivered; based at least partially on the determined difference, determine a second baseline basal rate to be utilized to deliver insulin during a second period of time that is at least 20 hours after an occurrence of the first period of time; and deliver insulin during the second period of time according to the second baseline basal rate. 15 . The system of claim 14 , wherein determining the second baseline basal rate comprising calculating the second baseline basal rate such that a difference between the second baseline basal rate and a third baseline basal rate originally associated with the second period of time is less than a difference between the first baseline basal insulin rate and the rate at which insulin was delivered during the first period of time. 16 . The system of claim 15 , wherein the second baseline basal rate is an increased rate relative to the third baseline basal rate originally associated with the second period of time if a ratio of the rate at which insulin was delivered during the first period of time to the first baseline basal insulin rate for the first period of time exceeds a predetermined first threshold and is a decreased rate relative to the third baseline basal rate if the ratio falls below a predetermined second threshold. 17 . The system of claim 16 , wherein the second baseline basal rate is the increased rate or the decreased rate relative to the third baseline basal rate by a fixed amount or a percentage that is less than a difference between the rate at which insulin was delivered during the first period of time and the first baseline basal insulin rate. 18 . The system of claim 15 , wherein a difference between the second baseline basal rate and the third baseline basal rate is based at least partially on the ratio, but is less than a difference between the rate at which insulin was delivered during the first period of time and the first baseline basal insulin rate. 19 . The system of claim 14 , wherein a commencement of the second period of time is at least 22 hours after a commencement of the first period of time. 20 . A system comprising: an insulin pump configured to deliver insulin; a glucose sensor configured to generate glucose data; and a controller comprising: at least one processor; and at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the controller to: monitoring a rate at which insulin is delivered during a first period of time; determining a difference between a previously stored first baseline basal rate associated with the first period of time and the rate at which insulin was delivered; based at least partially on the determined difference, adjusting a second baseline basal rate, to be u

Assignees

Inventors

Classifications

  • with memories providing a history of measured variating parameters of apparatus or patient · CPC title

  • using modem, internet or Bluetooth® · CPC title

  • sublocal, e.g. between console and disposable · CPC title

  • of the skin patch type · CPC title

  • Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025262381A1 cover?
A method may include delivering insulin, using an insulin pump and a controller, over a first diurnal time period based on a baseline basal insulin rate stored in memory. The controller may receive blood glucose data to control delivery of insulin via the insulin pump in amounts variable from the baseline basal insulin rate to control blood glucose levels for a person with diabetes (PWD). The m…
Who is the assignee on this patent?
Insulet Corp
What technology area does this patent fall under?
Primary CPC classification A61M5/142. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).